Waldencast plc (WALD) Investor Relations Documents

Waldencast plc (WALD) investor relations documents from the company's IR site: 27 press releases. Read in-app with summaries. First-party data.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-07-30Press releaseWaldencast Announces Completion of the Sale of Obagi Medical to BridgepointJuly 29, 2026
2026-07-30Press releaseWaldencast Announces Completion of the Sale of Obagi Medical to Bridgepoint
2026-06-15Press releaseObagi Medical Announces FDA Approval of Obagi® saypha® ChIQ™ Injectable Hyaluronic Acid Gel
2026-06-01Press releaseWaldencast Announces Sale of Obagi Medical to Bridgepoint
2026-05-15Press releaseObagi Medical Shares New Data on Recent Innovations at Music City Symposium for Cosmetic Advances & Laser Education
2026-05-14Press releaseObagi and Next Health Partner to Launch “The Skin Recharge Station” Pop-Up Experience
2026-04-30Press releaseObagi Medical Unveils New Mineral Sunscreen Designed to Protect Sensitive and Post-Procedure Skin*
2026-04-28Press releaseWaldencast announces conclusion of SEC investigation
2026-03-24Press releaseObagi Medical Introduces NU-GEN™ Cellular Renewal Serum Designed to Visibly Rewind Skin’s Age and Restore Visible Youthf
2026-03-19Press releaseObagi Medical and ProMD Announce Collaboration in the ALOHA Program to Advance Clinical Evidence with Obagi® saypha® Mag
2026-03-13Press releaseWaldencast Reports Q4 2025 and FY 2025 Financial Results
2026-03-11Press releaseWaldencast plc Announces Fourth Quarter and Fiscal Year 2025 Earnings Date
2026-02-27Press releaseObagi Medical and Schweiger Dermatology Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Oba
2026-02-25Press releaseObagi Medical and It’s a Secret Med Spa Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Oba
2026-02-17Press releaseObagi Medical and Aesthetic Record Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® s
2026-02-06Press releaseObagi Medical and DermFx Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® Mag
2026-02-03Press releaseObagi Medical Introduces New Lip Therapy Protocol Designed to Resurface, Replenish, and Protect
2026-01-30Press releaseObagi Medical and VIO Med Spa Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha
2026-01-28Press releaseObagi Medical and Next Health Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha
2026-01-27Press releaseObagi Medical and Alpha Aesthetic Partners Announce Their Collaboration in the ALOHA Program to Drive Real-World Evidenc
2026-01-26Press releaseObagi Medical and Platinum Dermatology Partners Announce Collaboration in the ALOHA Program to Drive Real-World Evidence
2026-01-21Press releaseObagi Medical Unveils ALOHA Program to Launch Obagi® saypha® MagIQ™January 21, 2026
2025-02-19Press releasePress release
2025-01-06Press releasePress release
2024-11-13Press releasePress release
Press releasePress release
Press releaseWaldencast PLC Announces Private Placement and Expands Leadership Team to Support Growth

WALD overview · WALD earnings · WALD financials · WALD KPIs · WALD ownership · WALD peers · WALD filings

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.